$CLPT

$9.69 +$0.65 (7.19%) Close

$CLPT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$CLPT Management Team

Mr. Joseph Burnett

President

Chief Executive Officer

Director

Age 48

Compensation $2.533M USD

Sex Male

Mr. Danilo D' Alessandro

Chief Financial Officer

Age 40

Compensation $1.166M USD

Sex Male

Mr. Mazin Sabra

Chief Operating Officer

Age 45

Compensation -

Sex Male

Mr. Jeremy Stigall

Chief Business Officer

Age 42

Compensation $1.134M USD

Sex Male

Mr. R. John Fletcher

Independent Chairman of the Board

Age 79

Compensation $227.2K USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Joseph Burnett President Chief Executive Officer Director	48	$2.533M USD	Male
Mr. Danilo D' Alessandro Chief Financial Officer	40	$1.166M USD	Male
Mr. Mazin Sabra Chief Operating Officer	45	-	Male
Mr. Jeremy Stigall Chief Business Officer	42	$1.134M USD	Male
Mr. R. John Fletcher Independent Chairman of the Board	79	$227.2K USD	Male

Board of Directors

From the proxy statement filed Apr 10, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 2 not stated

Average tenure

7.6 years

from year joined

CEO also chairs the board

R. John Fletcher

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Joseph M. Burnett CEO	49	2017 9 years	Not stated	None stated	None stated	Paid as CEO
R. John Fletcher Board chair	80	2017 9 years	Independent	Audit Committee Corporate Governance and Nominating Committee	KORU Medical Systems (Nasdaq: KRMD)	$242,645
Lynnette C. Fallon	66	2021 5 years	Independent	Audit Committee · Chair Corporate Governance and Nominating Committee	None stated	$219,997
B. Kristine Johnson	74	2019 7 years	Independent	Compensation Committee · Chair	Atricure, Inc. (Nasdaq: ATRC)	$207,497
Matthew B. Klein	54	2020 6 years	Not stated	None stated	None stated	$192,497
Linda M. Liau	59	2021 5 years	Independent	Compensation Committee	None stated	$199,997
Timothy T. Richards	68	2014 12 years	Independent	Compensation Committee Corporate Governance and Nominating Committee · Chair	None stated	$212,300
Pascal E.R. Girin Leaving at the meeting	Not stated	Not stated	Independent	Audit Committee	None stated	$202,638

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 10, 2026

PTC Therapeutics, Inc.

Dr. Klein, one of our directors, is PTC's Chief Executive Officer and President

$2.8 million and $2.9 million

2024 and 2025

Supply Agreement under which the company provides PTC with hardware, software, clinical case support and market development services; PTC made payments to the company under it

With Company Open in proxy

PTC Therapeutics, Inc.

Dr. Klein, one of our directors, is PTC's Chief Executive Officer and President

$10 million

January 2020 until August 2024

PTC held secured convertible notes issued by the Company

With Company Open in proxy

Comments

Company Executives

$CLPT Management Team

Mr. Joseph Burnett

Mr. Danilo D' Alessandro

Mr. Mazin Sabra

Mr. Jeremy Stigall

Mr. R. John Fletcher

Board of Directors

Related-party transactions